New method for classifying low and intermediate grade gliomas identified

A new method for classifying low and intermediate grade gliomas (LGGs) has recently been reported in the New England Journal of Medicine. This new approach – discovered utilizing molecular and genetic analysis – could lead to improvements in diagnosis, treatment and potentially patient outcomes, and also validates potential targets for future therapies. In order to develop the new method, researchers from 44 federally designated cancer centers throughout the United States performed a genome-wide analysis of 293 adult LGGs from centers belonging to The Cancer Genome Atlas Research Network (National Cancer Institute, NIH, MD, USA). The findings of the analysis were...